15th Nov 2005 12:15
Synairgen plc15 November 2005 PRESS RELEASE-------------------------- --------------------- SYNAIRGEN PLC ("Synairgen" or the "Company") RESULT OF AGM Synairgen, the drug discovery company focused on identifying the underlyingcauses of, and treatments for, asthma and chronic obstructive pulmonary disease(COPD) is pleased to announce that all the resolutions at the Annual General Meeting of the Company, held earlier today, 15 November 2005, were duly passed. -Ends- For further information, please contact: Synairgen Tel: 02380 512 800Richard Marsden, Managing Director Hogarth Partnership Tel: 020 7357 9477Melanie Toyne-Sewell / Georgina Briscoe This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Synairgen